The Online Investor
Drugs & Pharmaceuticals IPOs image Drugs & Pharmaceuticals IPOs » By The Online Investor Staff, updated Mon., Jan. 24, 1:24 AM
Recent initial public offerings in the Drugs & Pharmaceuticals IPOs category.

Slide #1. Syros Pharmaceuticals Initial Public Offering

Company: Syros Pharmaceuticals
Proposed Symbol: SYRS
Shares Offered: 4,000,000
Price Per Share: $12.50
Over-Allotment: 600,000
Description: Syros Pharmaceuticals today announced the pricing of its initial public offering of 4,000,000 shares of its common stock at a public offering price of $12.50 per share, before underwriting discounts and commissions. In addition, Syros has granted the underwriters a 30-day option to purchase up to 600,000 additional shares of common stock from Syros at the public offering price, less the underwriting discount and commissions, to cover over-allotments, if any. All of the shares are being offered by Syros Pharmaceuticals. The Company's shares are scheduled to begin trading on The NASDAQ Global Select Market on June 30, 2016 under the ticker symbol "SYRS." The offering is expected to close on July 6, 2016, subject to customary closing conditions.

IPOs: Syros Pharmaceuticals

List of Drugs & Pharmaceuticals IPOs in this Slideshow: Company Ticker IPO Date Regulus Therapeutics Inc. RGLS 10/4/2012 Intercept Pharmaceuticals, Inc ICPT 10/11/2012 Atossa Genetics, Inc. ATOS 11/8/2012 Zoetis ZTS PTC Therapeutics, Inc. PTCT Epizyme, Inc. EPZM Agios Pharmaceuticals, Inc. AGIO Onconova Therapeutics, Inc. ONTX Evoke Pharma, Inc. EVOK Karyopharm Therapeutics Inc. KPTI MacroGenics, Inc MGNX Trevena, Inc. TRVN Xencor XNCR ADMA Biologics ADMA Aerie Pharmaceuticals AERI Cara Therapeutics CARA Ultragenyx Pharmaceutical Inc. RARE Intra-Cellular Therapies ITCI uniQure B.V. QURE Revance Therapeutics RVNC Eagle Pharmaceuticals EGRX Concert Pharmaceuticals CNCE Akebia Therapeutics AKBA Recro Pharma, Inc. REPH Phibro Animal Health Corporation PAHC Galmed Pharmaceuticals GLMD Ignyta RXDX Agile Therapeutics, Inc. AGRX MediWound Ltd MDWD Phibro Animal Health Corporation PAHC Aldeyra Therapeutics ALDX Radius Health, Inc. RDUS Zosano Pharma Corporation ZSAN Amphastar Pharmaceuticals, Inc. AMPH Karyopharm Therapeutics Inc. KPTI Affimed AFMD Minerva Neurosciences, Inc. NERV SAGE Therapeutics, Inc SAGE Ocular Therapeutix OCUL VBL Therapeutics VBLT Catalent, Inc. CTLT Marinus Pharmaceuticals, Inc. MRNS ProQR Therapeutics PRQR Calithera Biosciences, Inc. CALA Bellicum Pharmaceuticals, Inc. BLCM Zosano Pharma Corporation ZSAN Ascendis Pharma A/S ASND RainDance Technologies, Inc. RAIN Blueprint Medicines Corporation BPMC Xbiotech XBIT KemPharm, Inc. KMPH 4/16/2015 Viking Therapeutics, Inc. VKTX Collegium Pharmaceutical, Inc. COLL Seres Therapeutics, Inc. MCRB vTv Therapeutics Inc. VTVT Zynerba Pharmaceuticals, Inc. ZYNE Nabriva Therapeutics AG NBRV Aclaris Therapeutics, Inc. ACRS CytomX Therapeutics, Inc. CTMX Mesoblast Limited MESO Corvus Pharmaceuticals, Inc. CRVS Aeglea BioTherapeutics, Inc. AGLE Merus B.V. MRUS Reata Pharmaceuticals, Inc. RETA Clearside Biomedical, Inc. CLSD Selecta Biosciences, Inc. SELB Syros Pharmaceuticals SYRS

Drugs & Pharmaceuticals IPOs Page | www.TheOnlineInvestor.com

Copyright © 1998 - 2022, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.